Skip to content

Welcome to Discover Pharma! Today is : October 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Sponsored Content

  • Clinical & Regulatory,Digital & Data,Research & Development

    CluePoints brings AI-powered clinical data review to DPHARM 2026

    AI and Robust Scientific Foundations to Optimize Clinical Trial Operations [...]

    September 16, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Research & Development

    How AI is reshaping clinical trials: Saama on the next phase of regulated AI

    Saama’s Chief Customer Success and Growth Officer Ari Srinivasan speaks [...]

    August 26, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics,Research & Development

    India’s CDMO market needs science, not just scale, says Lupin Manufacturing Solutions CEO

    In this exclusive interview with Liza Laws for Discover Pharma, [...]

    July 23, 2026
  • Biotech & Pharma Business,Digital & Data

    Turning AI Skeptics into AI Advocates Through High-Integrity Data

    With 89% of AI pilots failing to scale, biopharmas can [...]

    May 14, 2026
  • Biotech & Pharma Business,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    SGD Pharma highlights GLP-1 demand, supply chain pressure and sustainability focus at DCAT Week

    Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]

    May 5, 2026
  • Clinical & Regulatory,Therapeutic Areas

    Rare Disease Day 2026: Cereno Scientific advances disease-modifying therapies in PAH

    As Rare Disease Day 2026 shines a spotlight on patients [...]

    May 5, 2026
  • Therapeutic Areas

    Rare Disease Day 2026: Er-Kim pushes to close access gap in underserved markets

    As Rare Disease Day 2026 highlights the challenges faced by [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    5 Insights on Data Foundations From Top Pharma Leaders

    As the pharmaceutical industry moves from AI experimentation to execution, [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Affibody advances radioligand therapies for precision oncology

    On World Cancer Day (WCD), Affibody highlights its progress in [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    CuraCell highlights T-cell therapy advances for solid tumors on World Cancer Day

    On World Cancer Day (today, February 4), CuraCell highlights its [...]

    May 5, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Olink assay correlates with ELISA for measuring endothelin-1
    Categories: Clinical & Regulatory, Research & Development
  • BridgeBio gets FDA Priority Review for oral infigratinib in achondroplasia
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • ViiV’s Cabenuva achieves superior viral suppression in CROWN Phase 3b study
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top